Advisory Boards: consultative bodies for ethical, scientific, and technical matters.
International Scientific Advisory Group (ISAG)
The ISAG has been established to advise the General Assembly and the Steering Committee as decision-making support. This group will provide additional independent expertise and knowledge on scientific and technical matters that can inform the PROMISE approach and strategies.
Current members of the PROMISE ISAG
Professor and Marcus Chair of Infectious Diseases, Department of Pediatrics, Emory University School of Medicine
Larry J. Anderson, MD joined the Division of Pediatric Infectious Disease, Emory University School of Medicine as Professor and Marcus Chair of Infectious Diseases in 2010 after 33 years at the Centers for Disease Control and Prevention (CDC). His laboratory is focused on studies of the pathogenesis of respiratory syncytial virus (RSV) to guide vaccine development and the asthmatic immune response to RSV and rhinovirus to identify novel approaches to treating asthma exacerbations.
Professor & Head of the Department of Paediatrics and Child Health and Director of the School of Child and Adolescent Health at the University of Cape Town (UCT), South Africa.
After specialising in pediatrics Prof Zar did 3 years of sub-specialist training in pediatric pulmonology at Babies Hospital, Columbia Presbyterian Medical Centre, New York, USA. She then returned to South Africa, following an academic career (including a PhD) while working at UCT. Her work, encompassing research, clinical care, education, training, and advocacy, has focused on child lung health.
Guest Researcher at The National Institutes of Health
DR Miller is an experienced Director Research Center with a demonstrated history of working in the integration of biomedical research, economics, clinical and population health outcomes in public health at the federal and international levels. He is expert in the field of Public Health, Epidemiology, Virology and Vaccine Discovery/ Development with a focus on rapidly transmissible viral agents such as influenza, RSV, and other vaccine-preventable diseases.
Clinical Professor at the University of Colorado School of Medicine, Children’s Hospital Colorado and Colorado School of Public Health)
Dr. Simoes is working with the World Health Organization (WHO) for the management of common pediatric conditions in developing countries (Integrated Management of Childhood Illness) and studies the epidemiology, pathogenesis, and prevention of the short- and long-term effects of RSV infection in children. He has played a significant role in the WHO’s initiative to reduce childhood and infant mortality throughout the world with the development of a strategy called “Integrated Management of Childhood Illness.” He has worked on this initiative since 1989, including testing and implementing its guidelines in many countries throughout Africa, Asia, and Europe.
